Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Valion Bio (TIVC) Other Operating Expenses (2021 - 2025)

Valion Bio has reported Other Operating Expenses over the past 5 years, most recently at -$117000.0 for Q3 2025.

  • For Q3 2025, Other Operating Expenses changed N/A year-over-year to -$117000.0; the TTM value through Dec 2025 reached $488000.0, down 48.79%, while the annual FY2024 figure was $1.2 million, 44.14% down from the prior year.
  • Other Operating Expenses for Q3 2025 was -$117000.0 at Valion Bio, down from $426000.0 in the prior quarter.
  • Over five years, Other Operating Expenses peaked at $1.1 million in Q2 2022 and troughed at -$117000.0 in Q3 2025.
  • A 5-year average of $452777.8 and a median of $455000.0 in 2023 define the central range for Other Operating Expenses.
  • Biggest five-year swings in Other Operating Expenses: surged 226.09% in 2022 and later crashed 67.21% in 2024.
  • Year by year, Other Operating Expenses stood at $692000.0 in 2021, then dropped by 27.6% to $501000.0 in 2022, then soared by 46.71% to $735000.0 in 2023, then crashed by 67.21% to $241000.0 in 2024, then crashed by 148.55% to -$117000.0 in 2025.
  • Business Quant data shows Other Operating Expenses for TIVC at -$117000.0 in Q3 2025, $426000.0 in Q2 2025, and $179000.0 in Q1 2025.